Zhitong Finance App News, Hanson Pharmaceuticals (002412.SZ) issued an announcement. Recently, the company received approval from the State Drug Administration to issue a “Pharmaceutical Clinical Trial Approval Notice” to increase the function and treatment of Simotang oral liquid, and agreed to carry out clinical trials of this product for non-erosive reflux disease.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.